(Q38351120)

2 September 2017

1 reference

title

Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). (English)

1 reference

2 September 2017

main subject

hereditary angioedema

1 reference

based on heuristic

inferred from title

C1 inhibitor deficiency

1 reference

Geetika Sabharwal

1

1 reference

2 September 2017

Timothy Craig

series ordinal

2

1 reference

2 September 2017

publication date

10 February 2015

1 reference

Expert Review of Clinical Immunology

2 September 2017

published in

1 reference

2 September 2017

volume

11

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

319-327

1 reference

Treatment of hereditary angioedema: a review (CME).

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

C1 inhibitor deficiency: consensus document

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Hereditary angioedema: a broad review for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

HAE international home therapy consensus document.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Hereditary angioedema in women: specific challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

C1 inhibitor: molecular and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Recombinant human c1 inhibitor (conestat alfa): in the treatment of angioedema attacks in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Target levels of functional C1-inhibitor in hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

Benefits of progestin contraception in non-allergic angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1012502

10.1586/1744666X.2015.1012502

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference